Holly A. Jensen
About Holly A. Jensen
Holly A. Jensen is a Senior Scientist at Bristol Myers Squibb specializing in TME TRC Translational Research with extensive experience in oncology and immuno-oncology.
Title
Holly A. Jensen is currently a Senior Scientist at Bristol Myers Squibb, focusing on TME TRC Translational Research. She is based in Redwood City, California, United States.
Education and Expertise
Holly A. Jensen obtained her MS/PhD in Chemical Engineering with a focus on Biomolecular Engineering and Biomedical Sciences from Cornell University between 2009 and 2015. She also holds a BS in Chemical Engineering with a minor in Biochemistry from Rensselaer Polytechnic Institute, where she graduated cum laude in 2009.
Background in Chemical Engineering and Biomolecular Sciences
With over a decade of experience spanning both academic and industry settings, Holly A. Jensen is renowned for her work in oncology, immuno-oncology, biomarkers, targeted immunotherapy, and immune modulation strategies. Her roles have consistently emphasized translational research and biomarker assay development.
Expertise in Flow Cytometry and Immune Population Analysis
Holly A. Jensen is an expert in flow cytometry and immune population analysis. Her skills extend to tissue dissociation and ex vivo functional assays, as well as proficiency in mammalian tissue culture and various molecular biology techniques.